***THIS COURSE IS SOLD OUT***
The Pharma-Biotech Product & Company Valuation course is designed to teach a systematic approach to producing a valuation which can be used in investment rounds, mergers/acquisitions, licensing deals or strategic development decisions in the pharma-biotech world. It goes beyond the number-crunching techniques of most consultants and includes difficult to define qualitative factors which shape the risk profile of the company in question.
For more information, please visit our Pharma-Biotech Product & Company Valuation Course web page: https://www.bio.org/events/bio-executive-training-programs/product-company-valuation-course
Session ID: 37183